Pacific Biosciences of California, Inc. (PACB)
NASDAQ: PACB · Real-Time Price · USD
1.450
-0.040 (-2.68%)
Jun 1, 2026, 9:40 AM EDT - Market open
PACB Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, PACB stock has a consensus rating of "Buy" and an average price target of $2.46. The average 1-year stock price forecast is 69.66% higher than the current stock price, while the lowest is $1.50 (+3.45%) and the highest is $3.00 (+106.90%).
Price Target: $2.46 (+69.66%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for PACB stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 5 | 5 | 5 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Sell Reiterates $1 → $1.5 | Sell | Reiterates | $1 → $1.5 | +3.45% | May 11, 2026 |
| TD Cowen | TD Cowen | Buy Reiterates $3 | Buy | Reiterates | $3 | +106.90% | May 8, 2026 |
| Piper Sandler | Piper Sandler | Hold Reiterates $2 | Hold | Reiterates | $2 | +37.93% | May 8, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $3 | Buy | Reiterates | $3 | +106.90% | May 8, 2026 |
| Guggenheim | Guggenheim | Hold Maintains n/a | Hold | Maintains | n/a | n/a | Feb 12, 2026 |
Financial Forecast
Revenue This Year
172.30M
from 160.01M
Increased by 7.68%
Revenue Next Year
196.13M
from 172.30M
Increased by 13.83%
EPS This Year
-0.51
from -1.82
EPS Next Year
-0.42
from -0.51
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | 183.2M | 208.2M | |||||
| Avg | 172.3M | 196.1M | |||||
| Low | 161.7M | 181.6M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 |
|---|---|---|---|---|---|---|---|
| High | 14.5% | 20.8% | |||||
| Avg | 7.7% | 13.8% | |||||
| Low | 1.1% | 5.4% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | -0.49 | -0.25 | ||||
| Avg | -0.51 | -0.42 | ||||
| Low | -0.52 | -0.47 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by TipRanks. Financial forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.